The requested information is provided in Portable Document Format (PDF). To view and print this document you'll need to install a copy of the free Adobe® Acrobat® Reader®. If you already have Adobe Acrobat Reader installed click "View PDF" below. If you need the Acrobat Reader you can download it from the Adobe Acrobat Reader Download page.

View PDF Cancel

Don't show me this message again
You are leaving Suboxone.com. Links are provided as a public service and for informational purposes only. No endorsement is made or implied. Clicking on "Continue" will take you to a website that is outside the control of Reckitt Benckiser Pharmaceuticals. You are solely responsible for your interactions with such websites.

Continue Cancel

Links are provided as a public service and for informational purposes only.

Continue Cancel

IMPORTANT INFORMATION:
On December 8, 2006, Federal legislation was passed allowing physicians to treat up to 100 opioid dependent patients with Suboxone at any given time—a significant increase from the previous limit of 30 patients.

Read More Close

There may be doctors in your area participating in a study to measure opioid dependence treatment outcomes. Patients who meet the eligibility requirements to participate in this study can receive up to $225 in compensation to complete surveys about their treatment.

NOTE: This study is only open to patients not currently under the care of a physician for opioid dependence and are seeking a treatment provider.

Please call 1-866-455-8876 between 9:00 AM to 7:30 PM EST to get more information.

Close

Patients and Caregivers Healthcare Professionals
 



Resources
Nurses
Counselors
Pharmacists
SUBOXONE Certification
Treating Opioid Dependence
About SUBOXONE
Home

Identifying Dependence
Starting a Conversation
Language of Dependence
Webinars
Treatment Walk-through
Dosing Guide
Maintenance Therapy
Medically Supervised Withdrawal
SUBOXONE Webinars
Video presentations addressing the most common questions healthcare professionals have when starting to prescribe SUBOXONE
View Webinars
SUBOXONE Practice Management Tool Kit
Information about treating opioid dependence, including patient management, preparing your practice, creating a referral network, and more.
Get Started
Identifying Dependence

In 2003, an estimated 21.6 million Americans were classified as having a substance use disorder (9.1% of the population ages 12 and older).1

The nature of medicine gives physicians and nurses "the best opportunity" to intervene and interrupt the progression of substance abuse.2 However, most medical schools devote only a few hours to the topic.2 According to surveys conducted in 2000 by Columbia University, 94% of primary care physicians failed to diagnose substance abuse in patients who displayed "classic symptoms."2

Screening for opioid dependence is similar to screening for other chronic medical conditions: Disease symptoms and risk factors are detectable through a routine patient interview or physical examination.

Several of the physical and behavioral symptoms associated with opioid use are itemized in the lists below (these lists are not intended as diagnostic tools):

Physicians who believe a patient's symptoms warrant further screening are encouraged to do so (see Encouraging Patients to Open Up and General Guidelines for Screening Questions for techniques to help facilitate more effective patient communication).

Alternatively, if a patient's needs (in addition to possible dependence) exceed what can reasonably be addressed through your practice, you may want to consider referring that patient to another DATA 2000 certified physician.

Additional screening consideration: Laboratory tests (ie, blood or urine tests) for opioids are generally not recommended as routine screening tools, because in the absence of a comprehensive substance use assessment, positive results are still considered insufficient basis for a diagnosis of dependence.3,4

Laboratory tests are, however, commonly used to confirm a diagnosis of opioid dependence.3

Additional Resources

Physical Signs of Opioid Intoxication3


Physical Signs of Opioid Overdose3
Physical Signs of Opioid Misuse
Opioid misuse often accompanies opioid dependence. Consider further screening in patients with evidence of any of the following (assuming no other cause for symptoms is found, eg, medical condition or medication side effect)4:
Psychosocial Signs of Opioid Dependence
There are no known psychosocial signs of opioid dependence per se, but certain patterns are frequently observed among individuals dependent on opioids. Consider further screening in patients with evidence of any of the following4:

DSM-IV Criteria for Substance Dependence
Once a thorough patient assessment has been performed, a formal diagnosis of opioid dependence can be made. A substance dependence diagnosis, according to current Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) diagnostic schema, is based on clusters of behaviors and physiologic effects occurring within a specific time frame.7 A diagnosis of dependence always takes precedence over that of abuse, ie, a diagnosis of abuse is made only if the DSM-IV criteria for dependence have never been met.7

DEPENDENCE ABUSE
3 or more in a 12-month period 1 or more in a 12-month period (Symptoms must never have met criteria for dependence)
Tolerance (marked increase in amount; marked decrease in effect) Recurrent use resulting in failure to fulfill major role obligation at work, home, or school
Characteristic withdrawal symptoms; substance taken to relieve withdrawal Recurrent use in physically hazardous situations
Substance taken in larger amount and for longer period than intended Recurrent substance-related legal problems
Persistent desire or repeated unsuccessful attempt to quit Continued use despite persistent or recurrent social or interpersonal problems caused or exacerbated by substance
Much time/activity to obtain, use, recover  
Important social, occupational, or recreational activities given up or reduced  
Use continues despite knowledge of adverse consequences (eg, failure to fulfill role obligation, use when physically hazardous)  

In using the DSM-IV criteria, one should specify whether substance dependence is with physiologic dependence (ie, there is evidence of tolerance or withdrawal) or without physiologic dependence (ie, no evidence of tolerance or withdrawal). In addition, patients may be variously classified as currently manifesting a pattern of abuse or dependence or as in remission. Those in remission can be divided into 4 subtypes—full, early partial, sustained, and sustained partial—on the basis of whether any of the criteria for abuse or dependence have been met and over what time frame. The remission category can also be used for patients receiving agonist therapy (eg, methadone maintenance) or for those living in a controlled drug-free environment.

References
1. Substance Abuse and Mental Health Services Administration (SAMHSA). Results from the 2003 national survey on drug use and health: national findings. Rockville, Md: Department of Health and Human Services, SAMHSA, Office of Applied Studies; 2004. NSDUH Series H–25, DHHS Publication No. SMA 04-3964.
2. National Center on Addiction and Substance Abuse at Columbia University (CASA). Missed Opportunity: National Survey of Primary Care Physicians and Patients on Substance Abuse. New York: CASA, 2000.
3. Center for Substance Abuse Treatment (CSAT). Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series 40. DHHS Publication No. (SMA) 04-3939. Rockville, Md: Substance Abuse and Mental Health Services Administration, 2004.
4. Detection and Diagnosis of Opioid Dependence [CME course]. Available at: http://www.addictionCME.com. Accessed June 7, 2004.
5. Buprenorphine in the Treatment of Opioid Dependence [training CD-ROM]. Prairie Village, Kan: American Academy of Addiction Psychiatry; 2002.
6. Education center: is it something other than pain? Partners Against Pain website. Available at: partnersagainstpain.com/index-mp.aspx?sid=2&aid=7697. Accessed March 22, 2005.
7. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. 4th ed. Text Revision. Washington, DC: American Psychiatric Association; 2000.